RP-1776, a novel cyclic peptide, was isolated from the culture broth of Streptomyces sp. KY11784. RP-1776 selectively inhibited the binding of PDGF BB to the extracellular domain of the PDGF β-receptor with an IC50 value of 11±6 μm. Detailed binding experiments suggested that RP-1776 directly interacts with PDGF BB. RP-1776 inhibited the phosphorylation of the PDGF β-receptor induced by PDGF BB. These results suggested that RP-1776 antagonizes the signaling of PDGF BB probably through the inhibition of PDGF BB binding to the PDGF β-receptor.
CITATION STYLE
Toki, S., Agatsuma, T., Ochiai, K., Saitoh, Y., Ando, K., Nakanishi, S., … Matsuda, Y. (2001). RP-1776, a novel cyclic peptide produced by Streptomyces sp., inhibits the binding of PDGF to the extracellular domain of its receptor. Journal of Antibiotics, 54(5), 405–414. https://doi.org/10.7164/antibiotics.54.405
Mendeley helps you to discover research relevant for your work.